Your browser doesn't support javascript.
loading
Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients.
Gilmour, Nicola; Kern, Petra S; Alépée, Nathalie; Boislève, Fanny; Bury, Dagmar; Clouet, Elodie; Hirota, Morihiko; Hoffmann, Sebastian; Kühnl, Jochen; Lalko, Jon F; Mewes, Karsten; Miyazawa, Masaaki; Nishida, Hayato; Osmani, Anne; Petersohn, Dirk; Sekine, Shuichi; van Vliet, Erwin; Klaric, Martina.
Afiliação
  • Gilmour N; Unilever, Colworth Science Park, Bedford, MK44 1LQ, United Kingdom. Electronic address: Nicola.Gilmour@Unilever.com.
  • Kern PS; Procter & Gamble Services NV/SA, Temselaan/ Boechoutlaan, 1853, Strombeek-Bever, Belgium. Electronic address: kern.ps@pg.com.
  • Alépée N; L'Oréal, Research & Innovation, Aulnay-sous-Bois, Clichy, France. Electronic address: nathalie.alepee@rd.loreal.com.
  • Boislève F; Chanel, 135 Avenue Charles de Gaulle, 92521, Neuilly, France. Electronic address: fanny.boisleve@chanel.com.
  • Bury D; L'Oréal, Research & Innovation, Aulnay-sous-Bois, Clichy, France. Electronic address: dagmar.bury@rd.loreal.com.
  • Clouet E; Pierre Fabre, 3 Avenue Hubert Curien, 31100, Toulouse, France. Electronic address: http://elodie.clouet@piere_fabre.com.
  • Hirota M; Shiseido Global Innovation Centre, 1-2-11, Takashima, Nishi-ku, Yokohama-shi, Kanagawa, 220-0011, Japan. Electronic address: morihiko.hirota@shiseido.com.
  • Hoffmann S; Seh Consulting + Services, Stembergring 15, 33106, Paderborn, Germany. Electronic address: sebastian.hoffmann@seh-cs.com.
  • Kühnl J; Beiersdorf AG, Unnastraße 48, 20245, Hamburg, Germany. Electronic address: Jochen.Kuehnl@Beiersdorf.com.
  • Lalko JF; Estee Lauder Companies, 155 Pinelawn Road, Suite 300 South, Melville, NY, 11747, USA. Electronic address: jlalko@estee.com.
  • Mewes K; Henkel AG & Co. KGaA, Henkelstraße 67, 40589, Düsseldorf, Germany. Electronic address: Karsten.Mewes@henkel.com.
  • Miyazawa M; Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi, 321-3497, Japan. Electronic address: miyazawa.masaaki@kao.com.
  • Nishida H; Shiseido Global Innovation Centre, 1-2-11, Takashima, Nishi-ku, Yokohama-shi, Kanagawa, 220-0011, Japan. Electronic address: hayato.nishida@shiseido.com.
  • Osmani A; LVMH Recherche, 185 Avenue de Verdun, 45804, St Jean de Braye, France. Electronic address: aosmani@research.lvmh-pc.com.
  • Petersohn D; Kao Corporation, 2606 Akabane, Ichikai, Haga, Tochigi, 321-3497, Japan. Electronic address: Dirk.Petersohn@henkel.com.
  • Sekine S; Shiseido Global Innovation Centre, 1-2-11, Takashima, Nishi-ku, Yokohama-shi, Kanagawa, 220-0011, Japan. Electronic address: shuichi.sekine@shiseido.com.
  • van Vliet E; Innovitox Consulting & Services, Regentenland 35, 3994TZ, Houten, the Netherlands. Electronic address: vanvliete@gmail.com.
  • Klaric M; Cosmetics Europe, Avenue Herrmann Debroux 40, 1160, Brussels, Belgium. Electronic address: martina_klaric@huntsman.com.
Regul Toxicol Pharmacol ; 116: 104721, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32645429
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pele / Alérgenos / Medição de Risco / Cosméticos / Haptenos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pele / Alérgenos / Medição de Risco / Cosméticos / Haptenos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2020 Tipo de documento: Article